4//SEC Filing
McKechnie William Edward 4
Accession 0001855763-23-000004
CIK 0001348362other
Filed
Jul 24, 8:00 PM ET
Accepted
Jul 25, 2:09 PM ET
Size
12.3 KB
Accession
0001855763-23-000004
Insider Transaction Report
Form 4
McKechnie William Edward
Director
Transactions
- Award
Stock Options
2023-07-25+5,000→ 35,000 totalExercise: $0.87From: 2023-07-25Exp: 2028-07-25→ Common Shares (5,000 underlying)
Holdings
- 1,500
Stock Options
Exercise: $3.00From: 2021-04-26Exp: 2026-04-26→ Common Shares (1,500 underlying) - 6,500
Stock Options
Exercise: $3.00From: 2021-06-08Exp: 2026-06-08→ Common Shares (5,000 underlying) - 8,400
Stock Options
Exercise: $3.00From: 2021-09-01Exp: 2026-09-01→ Common Shares (1,900 underlying) - 13,191
common shares
- 11,800
Stock Options
Exercise: $3.39From: 2022-03-08Exp: 2027-03-08→ Common Shares (3,400 underlying) - 30,000
Stock Options
Exercise: $1.96From: 2022-10-12Exp: 2027-10-12→ Common Shares (18,200 underlying)
Footnotes (3)
- [F1]Repriced from $5.31 pursuant to shareholder approval received on May 9, 2023
- [F2]Repriced from $7.08 pursuant to shareholder approval received May 9, 2023
- [F3]Repriced from $6.23 pursuant to shareholder approval received May 9, 2023
Documents
Issuer
Lexaria Bioscience Corp.
CIK 0001348362
Entity typeother
Related Parties
1- filerCIK 0001658613
Filing Metadata
- Form type
- 4
- Filed
- Jul 24, 8:00 PM ET
- Accepted
- Jul 25, 2:09 PM ET
- Size
- 12.3 KB